[On polythymolepsy (combined application of thymoleptics) in endogenous depression].
D000328:Adult; D000342:Affective Symptoms / Q000188:drug therapy*; D000639:Amitriptyline / Q000627:therapeutic use; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D003984:Dibenzazepines / Q000627:therapeutic use; D004357:Drug Synergism; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007099:Imipramine / Q000627:therapeutic use; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D013881:Thioridazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D003984:Dibenzazepines; D006993:Hypnotics and Sedatives; D008996:Monoamine Oxidase Inhibitors; D014149:Tranquilizing Agents; D000639:Amitriptyline; D002707:Chlordiazepoxide; D013881:Thioridazine; D007099:Imipramine; D002746:Chlorpromazine
Ergebnisse, Kasuistik und Diskussionen Uber Plythymolepsie (kombinierte Anwendung von Thymoleptika) bei endogener Depression.